LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 195

Search options

  1. Book ; Online ; E-Book: Behçet syndrome

    Yazici, Yusuf / Hatemi, Gulen / Seyahi, Emire / Yazici, Hasan

    2020  

    Author's details Yusuf Yazici, Gulen Hatemi, Emire Seyahi, Hasan Yazici editors
    Keywords Electronic books
    Language English
    Size 1 Online-Ressource (xvi, 328 Seiten), Illustrationen
    Edition Second edition
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT020383341
    ISBN 978-3-030-24131-5 ; 9783030241308 ; 3-030-24131-9 ; 3030241300
    DOI 10.1007/978-3-030-24131-5
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Full text online

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: Current treatment approach to ANCA-associated vasculitis.

    Yazici, Yusuf

    Current opinion in rheumatology

    2023  Volume 36, Issue 1, Page(s) 35–39

    Abstract: Purpose of review: This review will attempt to summarize the most potentially impactful new data on the way ANCA-associated vasculitis (AAV) is diagnosed, treated, and monitored.: Recent findings: The newly developed classification criteria for AAV ... ...

    Abstract Purpose of review: This review will attempt to summarize the most potentially impactful new data on the way ANCA-associated vasculitis (AAV) is diagnosed, treated, and monitored.
    Recent findings: The newly developed classification criteria for AAV have serious methodological issues that need to be addressed before they are widely adopted. The newly approved drugs and studies into both achieving remission and maintaining it have added to our overall knowledge of managing AAV and should hopefully contribute to improving outcomes in AAV.
    Summary: The diagnosis, treatment and monitoring of AAV have seen major improvements in the last two years. The remaining issues outlined in this review still need to be addressed to best serve AAV patients.
    MeSH term(s) Humans ; Antibodies, Antineutrophil Cytoplasmic ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Remission Induction
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2023-10-09
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3028: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Book: Methotrexate: New ideas in optimizing treatment in rheumatoid arthritis

    Yazici, Yusuf

    (Bulletin of the NYU Hospital for Joint Diseases ; 71, Suppl. 1)

    2013  

    Author's details guest ed. Yusif Yazici
    Series title Bulletin of the NYU Hospital for Joint Diseases ; 71, Suppl. 1
    Bulletin of the Hospital for Joint Diseases
    Collection Bulletin of the Hospital for Joint Diseases
    Language English
    Size S48 S. : graph. Darst.
    Publisher Ryan
    Publishing place Andover, NJ
    Publishing country United States
    Document type Book
    HBZ-ID HT018105735
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Uk I Zs 233 -71,Suppl.1- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Are Disease Classification Criteria for Diagnosis or for Research? In Fact, for Neither.

    Yazici, Hasan / Yazici, Yusuf

    The Journal of rheumatology

    2024  Volume 51, Issue 2, Page(s) 114–116

    Language English
    Publishing date 2024-02-01
    Publishing country Canada
    Document type Editorial
    ZDB-ID 194928-7
    ISSN 1499-2752 ; 0315-162X
    ISSN (online) 1499-2752
    ISSN 0315-162X
    DOI 10.3899/jrheum.2023-0338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1168: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 135: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Book: Corticosteroids in the treatment of rheumatoid arthritis

    Yazici, Yusuf

    a 2012 update

    (Bulletin of the NYU Hospital for Joint Diseases ; 70, Suppl. 1)

    2012  

    Author's details guest ed. Yusif Yazici
    Series title Bulletin of the NYU Hospital for Joint Diseases ; 70, Suppl. 1
    Bulletin of the Hospital for Joint Diseases
    Collection Bulletin of the Hospital for Joint Diseases
    Language English
    Size S36 S. : graph. Darst.
    Publisher Ryan
    Publishing place Andover, NJ
    Publishing country United States
    Document type Book
    HBZ-ID HT017500050
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Uk I Zs 233 -70,Suppl.1- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Book: Behçet's syndrome

    Yazici, Yusuf

    2010  

    Author's details Yusuf Yazıcı
    Keywords Behcet Syndrome
    Language English
    Size XVI, 347 S. : zahlr. Ill., graph. Darst., 235 mm x 155 mm
    Publisher Springer Science+Business Media
    Publishing place New York, NY u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT016554391
    ISBN 978-1-441-95640-8 ; 9781441956415 ; 1-441-95640-9 ; 1441956417
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2010 A 5090 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: Introduction, Vasculitis 2023.

    Yazici, Hasan / Yazici, Yusuf

    Current opinion in rheumatology

    2023  Volume 36, Issue 1, Page(s) 1–2

    MeSH term(s) Humans ; Vasculitis
    Language English
    Publishing date 2023-11-30
    Publishing country United States
    Document type Introductory Journal Article
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000984
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3028: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Outcome measures in Behçet syndrome.

    Hatemi, Gülen / Yazici, Yusuf

    Clinical immunology (Orlando, Fla.)

    2023  Volume 251, Page(s) 109341

    Abstract: Disease assessment has been challenging in Behçet syndrome due to the heterogeneous disease course and multiorgan involvement with variable treatment response. There have been several recent improvements regarding outcome measures including development ... ...

    Abstract Disease assessment has been challenging in Behçet syndrome due to the heterogeneous disease course and multiorgan involvement with variable treatment response. There have been several recent improvements regarding outcome measures including development of a Core Set of Domains for Behçet syndrome and novel instruments for assessing specific organs and overall damage. This review focuses on the current state of outcome measures in Behçet syndrome, unmet needs, and a research agenda towards the development of standardized and validated outcome measure instruments.
    MeSH term(s) Humans ; Behcet Syndrome/diagnosis ; Behcet Syndrome/therapy ; Outcome Assessment, Health Care ; Disease Progression
    Language English
    Publishing date 2023-04-24
    Publishing country United States
    Document type Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2023.109341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 880: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Difficult-to-treat Behçet syndrome: A therapeutic approach.

    Yazici, Yusuf / Hatemi, Gulen

    Clinical immunology (Orlando, Fla.)

    2023  Volume 249, Page(s) 109272

    Abstract: Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe ... ...

    Abstract Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients.
    MeSH term(s) Humans ; Behcet Syndrome/drug therapy
    Language English
    Publishing date 2023-02-21
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2023.109272
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 880: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: Management of Behçet syndrome.

    Yazici, Yusuf

    Current opinion in rheumatology

    2019  Volume 32, Issue 1, Page(s) 35–40

    Abstract: Purpose of review: New treatment options have been studied over the last several years, with a recent approval, a first for Behçet syndrome, in the United States. New management guidelines have also been published, helping with this nowadays more ... ...

    Abstract Purpose of review: New treatment options have been studied over the last several years, with a recent approval, a first for Behçet syndrome, in the United States. New management guidelines have also been published, helping with this nowadays more commonly recognized condition's management. The goal of this review is to summarize the most important and potentially clinically relevant recent developments and discuss their impact in the management of patients with Behçet syndrome.
    Recent findings: Apremilast is now approved for the treatment of oral ulcer of Behçet syndrome in the United States. It's possible benefits in controlling nonoral ulcer features of the syndrome are awaited. Long-term use of tumor necrosis factor inhibitors for the treatment of especially eye disease in Behçet syndrome seems to be safe and efficacious. New treatment options such as ustekinumab, secukinumab, tocilizumab and others have early promising data but more studies are needed to better clarify their role in Behçet management.
    Summary: The last 2 years have not only seen the approval of the first drug specifically labeled for the treatment of Behçet syndrome in the case of apremilast, many groups have also presented and published their findings on promising new therapeutic agents, which may soon be added to our tools in treating this condition. We also know more about other drugs, such as tumor necrosis factor inhibitors as many patients have been on these for long periods of time, and long-term follow-up data seem to confirm their role in Behçet treatment. Lack of placebo controlled, randomized trials, for the most part, are still outstanding issues.
    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Behcet Syndrome/drug therapy ; Humans ; Thalidomide/analogs & derivatives ; Thalidomide/therapeutic use ; Ustekinumab/therapeutic use
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Thalidomide (4Z8R6ORS6L) ; secukinumab (DLG4EML025) ; Ustekinumab (FU77B4U5Z0) ; tocilizumab (I031V2H011) ; apremilast (UP7QBP99PN)
    Language English
    Publishing date 2019-10-14
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000666
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3028: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top